Advertisement
Table 2 Demographic data and base-line data for the major outcome assessments of participants evaluated at the end of a run-in period (week 0).
| Treatment groups | |||
|---|---|---|---|
| Characteristics | DJW | Diclofenac | p value |
| n (M:F) | 100 (22:78) | 100 (19:81) | NS |
| Age (y)* | 62.66 (9.46) | 62.38 (8.22) | NS |
| Body weight (kg)* | 60.47 (10.34) | 60.13 (10.89) | NS |
| Height (m)* | 1.51 (0.07) | 1.51 (0.07) | NS |
| BMI (kg/m2)* | 26.52 (4.38) | 26.35 (3.85) | NS |
| Duration of OA (y)* | 5.46 (5.48) | 4.79 (4.24) | NS |
| Localization of OA | NS | ||
| Right knee | 17 | 17 | |
| Left knee | 14 | 14 | |
| Both knees | 69 | 69 | |
| VAS the assessed pain (mm)* | |||
| Walking pain | 64.53 (24.92) | 64.78 (25.14) | NS |
| Standing pain | 52.42 (25.87) | 53.52 (24.69) | NS |
| Pain during climbing up and down stairs | 63.08 (20.87) | 62.69 (23.21) | NS |
| Night pain | 50.15 (26.74) | 48.45 (28.18) | NS |
| Resting pain | 38.48 (22.09) | 37.12 (26.08) | NS |
| Total paina | 268.65 (88.87) | 266.55 (89.33) | NS |
| Pain during the most painful knee movement | 82.25 (16.15) | 81.17 (16.56) | NS |
| VAS that assessed stiffness (mm)* | |||
| Morning stiffness | 53.53 (27.38) | 58.32 (26.40) | NS |
| Stiffness after rest | 68.52 (22.76) | 70.45 (22.32) | NS |
| Total stiffnessb | 122.05 (41.98) | 128.76 (42.34) | NS |
| Lequesne's functional index* | 14.20 (3.13) | 14.80 (2.61) | NS |
| Time for climbing up 10 steps* | 13.44 (4.85) | 13.32 (5.10) | NS |
